Exceptional outcome: CD-30-positive relapsed enteropathy-associated T-cell lymphoma (EATL) treated with brentuximab vedotin alone, showing significant improvement in weight and albumin levels in Type II refractory coeliac disease: a case report
Introduction: Enteropathy-associated T-cell lymphoma (EATL) is the neoplastic transformation of intraepithelial T lymphocytes emerging in coeliac patients unresponsive to a gluten-free diet.1 Type 2 refractory coeliac disease (RCD II) is a precursor of EATL; therefore, RCD II has been added to the I...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Clinical Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211825001162 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|